News

Info sheet on right-to-react (rebuttal) procedure pilot under Horizon Europe

Published on | 4 years ago

Programmes
Agro-Food, Environment EIC Widening/Spreading Horizon Europe HorizonEU L+F

A pilot on right-to-react (or rebuttal) in the evaluation procedure of proposals was previously announced for the second/third quarter in 2021. The experts reviewing the proposals would have to take into account the input provided by the applicants during the evaluation process in the final Evaluation Summary Reports (ESR). For this pilot four calls in the Horizon Europe 2021-2022 work programme were selected:

HORIZON-EIC-2021-PATHFINDEROPEN-01

HORIZON-CL6-2021-BIODIV-02

HORIZON-CL6-2022-COMMUNITIES-02

HORIZON-WIDERA-2022-TALENTS-01

A short summary of this rebuttal pilot has been made available on the NCP Flanders website on the Horizon Europe programme pages of Legal and Financial Issues, European Innovation Council (EIC), Cluster 6 and Widening Participation and Spreading Excellence and you can find the info sheet here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1802 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.